• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酮症高甘氨酸血症:临床、生化及治疗方面的考量

Nonketotic hyperglycinemia: clinical, biochemical, and therapeutic considerations.

作者信息

Langan T J, Pueschel S M

出版信息

Curr Probl Pediatr. 1983 Jan;13(3):1-30. doi: 10.1016/0045-9380(83)90016-6.

DOI:10.1016/0045-9380(83)90016-6
PMID:6301756
Abstract

The salient features of nonketotic hyperglycinemia include apnea, feeding difficulties, lethargy, seizures, abnormal muscle tone and reflex activity, significant developmental delay, and, in most instances, early death. The pathogenesis of the biochemical defect leading to increased glycine concentration in blood, urine, and CSF is likely to concern derangements of the glycine cleavage enzyme and/or transport mechanisms of glycine. Our current state of knowledge of this disorder is incomplete. Therapeutic attempts, as described in Table 2, have been largely unsuccessful. Further basic research on the underlying biochemical perturbation, including additional documentation of the glycine cleavage enzyme deficiency patterns, of substrate inhibition of key metabolic pathways, and of glycine transport aberrations, as well as investigations of new pharmacologic approaches, will be a challenge for investigators in this field. It is hoped that new knowledge in these areas will eventually lead to reduction of morbidity and mortality in children with nonketotic hyperglycinemia.

摘要

非酮症高甘氨酸血症的显著特征包括呼吸暂停、喂养困难、嗜睡、癫痫发作、肌张力和反射活动异常、严重发育迟缓,且在大多数情况下会早期死亡。导致血液、尿液和脑脊液中甘氨酸浓度升高的生化缺陷的发病机制可能与甘氨酸裂解酶和/或甘氨酸转运机制紊乱有关。我们目前对这种疾病的了解尚不完整。如表2所述,治疗尝试大多未成功。对潜在生化紊乱进行进一步的基础研究,包括甘氨酸裂解酶缺乏模式的更多记录、关键代谢途径的底物抑制以及甘氨酸转运异常,以及新的药理学方法研究,将是该领域研究人员面临的一项挑战。希望这些领域的新知识最终能降低非酮症高甘氨酸血症患儿的发病率和死亡率。

相似文献

1
Nonketotic hyperglycinemia: clinical, biochemical, and therapeutic considerations.非酮症高甘氨酸血症:临床、生化及治疗方面的考量
Curr Probl Pediatr. 1983 Jan;13(3):1-30. doi: 10.1016/0045-9380(83)90016-6.
2
Nonketotic hyperglycinemia. Clinical, biochemical and therapeutic aspects.非酮症高甘氨酸血症。临床、生化及治疗方面。
Acta Paediatr Scand. 1979 Jul;68(4):629-34. doi: 10.1111/j.1651-2227.1979.tb05072.x.
3
Attempts at use of strychnine sulfate in the treatment of nonketotic hyperglycinemia.尝试使用硫酸士的宁治疗非酮症高甘氨酸血症。
Pediatrics. 1980 Jan;65(1):61-4.
4
Nonketotic hyperglycinemia. Effects of therapy with strychnine.非酮症高甘氨酸血症。士的宁治疗效果
Am J Dis Child. 1980 Mar;134(3):273-5. doi: 10.1001/archpedi.1980.02130150031008.
5
Nonketotic hyperglycinemia.
J Pediatr. 1969 Dec;75(6):1022-30. doi: 10.1016/s0022-3476(69)80341-0.
6
Strychnine therapy in nonketotic hyperglycinemia.
Pediatrics. 1979 Mar;63(3):369-73.
7
A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches.一名非酮症高甘氨酸血症患者:生化检查结果及治疗方法
Pediatr Res. 1974 May;8(5):598-605. doi: 10.1203/00006450-197405000-00009.
8
Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
Prog Clin Biol Res. 1979;34:217-29.
9
[Molecular pathology of the hyperglycinemias].[高甘氨酸血症的分子病理学]
Rev Esp Fisiol. 1982;38 Suppl:199-205.
10
Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
Pediatrics. 1980 Jun;65(6):1166-9.

引用本文的文献

1
Comprehensive behavioral analyses of mice with a glycine receptor alpha 4 deficiency.甘氨酸受体α4 缺失小鼠的综合行为分析。
Mol Brain. 2023 May 22;16(1):44. doi: 10.1186/s13041-023-01033-x.
2
Glycine encephalopathy.甘氨酸脑病
Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):132. doi: 10.1186/s41983-022-00567-6. Epub 2022 Nov 17.
3
Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship.
J Inherit Metab Dis. 1997 Mar;20(1):28-38. doi: 10.1023/A:1005301321635.